RE: RE: RE: RE: RE: RE: RE: RE: RE: RE: RE: RE: RE Thanks. But I still think the buying is material. Do you have a spare $20K that you want to buy into the company? The board member did. Considering that he's probably a board member of other companies and has other investments, using his investment money to dump into KNE is a positive sign, no matter what everyone's personal opinion is on materiality. Especially since he is involved in the capital markets. Probably is getting all his institutional buddies in on it too at these low levels.
It outlines that the DispersinB is still in application for stuff beyong household use. Still what do you want from a $5M market cap company? If DispersinB was the cure for cancer it would be a $200M market cap now. It's already been approved for household use and the US Army likes it. There's a good chance it'll be approved for more.
Also, I'm willing to bet that the Lysol product line is worth more to Reckitt (the maker of Lysol) than $5M. So even if its only good for household, it's worth a lot more than 9 cents anyways.
True on the warrants but that's still not that much, it's at much higher prices than 9 cents, and if exercised, the company gets money in the bank. Warrants are anti-dilutive tools when at higher strike prices. If KNE is $1, then yea, watch out for those warrants.